SLC16A4 and neoplasm: SLC16A4 expression was found to be significantly negatively correlated with tumor stemness as quantified by RNA-based stemness scores (RNAss) (r = −0.585, Figure 12A) and similarly showed a strong negative correlation with the expression of the stemness-associated marker gene SOX2 (r = −0.551, Figure 12B).